Kelonia Therapeutics

📍 Boston, United States👥 48 employees💰 Last funded Apr 2022
Biotechnology🌐 keloniatx.com
Website LinkedIn
Kelonia is pioneering a new wave of genetic medicines using its next generation gene delivery platform. The company’s simple and elegant cutting-edge in vivo gene delivery technology uses a few potent lentiviral vector-like particles to precisely and efficiently deliver in vivo genetic cargo to the desired target tissue, and only that tissue, every time. With an initial focus on developing transformational therapies for solid tumors and hematologic cancers, Kelonia is building a pipeline of genetic medicines for a wide range of diseases, with the bold goal of bringing genetic medicines to every patient in need.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Hong Kong SAR
1
Frequently asked questions
Who invested in Kelonia Therapeutics?
Kelonia Therapeutics has 1 investors on record on gritt.io.
When did Kelonia Therapeutics last raise funding?
The most recent investment in Kelonia Therapeutics recorded on gritt.io was in April 2022.
What industry is Kelonia Therapeutics in?
Kelonia Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Kelonia Therapeutics based?
Kelonia Therapeutics is headquartered in Boston, United States.